COPD: New Developments-Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and disability. More than 12 million people are diagnosed with COPD in the United States, and another 12 million may be undiagnosed. The condition is the fourth leading cause of death in the U.S. This presentation discusses the pathogenesis and diagnosis of COPD; reviews the findings of recent trials with evidence-based treatment options for COPD; and discusses new and evolving treatments for COPD, including PDE-4 inhibitors.
Explain the pathogenesis and diagnosis of COPD.
Discuss findings of recent trials and evidence based treatment options for COPD.
Explore new and evolving treatments including PDE-4 inhibitors for COPD.
1.0 Free AMA Pra CAT 1 CME for Physicians
Expires 1/24/14
Actelion, Boehringer Ingelheim, CSL Behring, Gilead Sciences, Inc., and United Therapeutics provided commercial support for this enduring activity.